NEURO & NOOTROPIC

Dihexa 20mg

Neuro and nootropic research compound.

20 mgRUO · RESEARCH USE ONLY$78.99

Bundle & save

1

Free shipment protection · Overnight shipping available · Ships from our Naples, FL facility

Free shipping

on orders over $150

Damage protection

replacement guarantee

Secure checkout

256-bit SSL

Certificate of Analysis

Third-party tested · ISO/IEC 17025 accredited

LATESTISO 170257+ TESTING

99%

purity

✓ Passed full QC panel

Variant
Dihexa 20mg · 20 mg
Lot #
TBD
Labeled
20 mg
Tested

Full QC panel

Purity (HPLC)
99%
Net Peptide Content
Pass
Identity (HPLC-MS)
Confirmed
Heavy Metals (ICP-MS)
Not detected
Sterility
No growth
Endotoxin (LAL)
Within limits
VIEW COA →

Purity, lot and tested date are per-lot; remaining QC rows are representative — exact values on the CoA.

Compound Information

Chemical and structural properties

Chemical identity verified via NIH PubChem · biological targets characterized from the peer-reviewed literature.

Molecular profile

Structure

CAS Number
1401708-83-5
Molecular Formula
C27H44N4O5
Molecular Weight
504.7 g/mol
Sequence
(see COA)
Type
Research peptide

Biological targets

Interactions

Primary target
Hepatocyte growth factor (HGF) / c-Met system
Pathway
HGF / c-Met-driven synaptogenesis
Mechanism
Angiotensin-IV-derived oligopeptide; HGF / c-Met potentiator
Research area
Synaptogenesis and cognition research

Physical properties

Handling & Storage

Appearance
White to off-white solid
Solubility
Soluble in DMSO or ethanol; limited aqueous solubility
Storage
2-8 deg C, protect from light
Country of origin
USA

Sources & References

Peer-reviewed research

Indexed in NIH PubMed. Provided for research context; not a claim of clinical outcome.

  • ANNALS OF MEDICINE AND SURGERY (2012)

    Stem cell, Granulocyte-Colony Stimulating Factor and/or Dihexa to promote limb function recovery in a rat sciatic nerve damage-repair model: Experimental animal studies

    2021 · PMID 34703584

    Weiss JB et al.

    View Source ↗
  • THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

    The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system

    2014 · PMID 25187433

    Benoist CC et al.

    View Source ↗
  • JOURNAL OF HUNTINGTON'S DISEASE

    Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats

    2024 · PMID 38489193

    Wells RG et al.

    View Source ↗
  • JOURNAL OF ALZHEIMER'S DISEASE : JAD

    The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease

    2015 · PMID 25649658

    Wright JW et al.

    View Source ↗
  • FRONTIERS IN CELLULAR NEUROSCIENCE

    Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure

    2015 · PMID 25674052

    Uribe PM et al.

    View Source ↗

⚠ Important research notice

PRODUCTS ARE INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly prohibited by law. Products should only be handled by licensed, qualified professionals. Products sold are not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food, or cosmetic.

All the research peptides you need, with the peace of mind at your fingertips.

Research updates from Aminologix

Catalog updates, new research compounds, and quality-documentation news. For researchers and labs. No spam, unsubscribe anytime.